Viewing Study NCT06199232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2026-01-15 @ 5:28 AM
Study NCT ID: NCT06199232
Status: RECRUITING
Last Update Posted: 2024-12-04
First Post: 2023-12-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed from Standard Systemic Treatment
Sponsor: Peking University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Metastasis Colon Cancer View
None CtDNA Genotype View
None MSS View
None Failed from Standard Treatment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatic arterial infusion chemotherapy View
None targeted therapy View
None tislelizumab View
None ctDNA genotype View
None MSS CRCLM View